Avalo Therapeutics Inc (AVTX) USD0.001

Sell:$13.67Buy:$13.76Price increased$0.31 (2.31%)

Prices delayed by at least 15 minutes
Sell:$13.67
Buy:$13.76
Change:Price increased$0.31 (2.31%)
Prices delayed by at least 15 minutes
Sell:$13.67
Buy:$13.76
Change:Price increased$0.31 (2.31%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
6 April 2026
Mittie DoyleChief Level Officer
Sell
Option/Award related
3,970$18.01$71,508.433,622
2 April 2026
Christopher Ryan (Chris) SullivanCFO
Sell
Regular sell transaction (market)
6,200$17.02$105,553.1419,118
2 April 2026
Christopher Ryan (Chris) SullivanCFO
Sell
Regular sell transaction (market)
1,780$17.57$31,269.9717,338
1 April 2026
Christopher Ryan (Chris) SullivanCFO
Sell
Regular sell transaction (market)
500$15.86$7,929.0032,797
1 April 2026
Christopher Ryan (Chris) SullivanCFO
Sell
Regular sell transaction (market)
7,479$16.83$125,840.9125,318
1 April 2026
Mittie DoyleChief Level Officer
Sell
Option/Award related
679$16.00$10,864.003,622
28 March 2026
Garry Arthur NeilChairman/CEO
Sell
Tax related
21,892$13.89$304,079.8890,114
28 March 2026
Christopher Ryan (Chris) SullivanCFO
Sell
Tax related
8,241$13.89$114,467.4933,297
16 March 2026
Mittie DoyleChief Level Officer
Sell
Option/Award related
25,492$16.15$411,606.583,622
10 December 2025
Christopher Ryan (Chris) SullivanCFO
Sell
Tax related
155$4.10$635.5017,338

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
16 March 2026
Mittie DoyleChief Level Officer
Sell
Option/Award related
25,492$16.15$411,606.583,622
28 March 2026
Garry Arthur NeilChairman/CEO
Sell
Tax related
21,892$13.89$304,079.8890,114
1 April 2026
Christopher Ryan (Chris) SullivanCFO
Sell
Regular sell transaction (market)
7,479$16.83$125,840.9125,318
14 November 2025
Jonathan GoldmanDirector
Sell
Option/Award related
8,200$14.35$117,648.680
28 March 2026
Christopher Ryan (Chris) SullivanCFO
Sell
Tax related
8,241$13.89$114,467.4933,297

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.